Immune Response of Healthy Adults to the Ingested Probiotic Lactobacillus casei Shirota.
- 2016-12
- Clinical Trial
- Scandinavian journal of immunology 84(6)
- L S Harbige
- E Pinto
- J Allgrove
- L V Thomas
- PubMed: 27718254
- DOI: 10.1111/sji.12495
- Moderate evidence
- Adults
LcS did not affect systemic circulating influenza A-specific IgA or IgG and tetanus-specific IgG antibody levels
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 1.3 × 10^10 live cells/day